Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study.
about
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disordersThe therapeutic potential of cannabis and cannabinoidsTreatment strategies for radioactive iodine-refractory differentiated thyroid cancerMarijuana Legalization: Impact on Physicians and Public HealthA user's guide to cannabinoid therapies in oncologyFunctioning and health in patients with cancer on home-parenteral nutrition: a qualitative study.Are we closer to having drugs to treat muscle wasting disease?Sarcopenia, cachexia and aging: diagnosis, mechanisms and therapeutic options - a mini-review.Clinical anticachexia treatments.Novel treatments for cancer cachexia.Treatment of cachexia in oncologyTreatment of the cancer anorexia-cachexia syndrome: a critical reappraisal.A structured exercise program for patients with advanced non-small cell lung cancerTherapeutic potential of cannabinoid medicines.Marijuana and body weightCancer cachexia: mechanisms and clinical implications.Pancreatic cancer cachexia: a review of mechanisms and therapeutics.Cancer cachexia, mechanism and treatmentThe cannabinoid receptor agonist THC attenuates weight loss in a rodent model of activity-based anorexia.Nutritional interventions for cancer-induced cachexiaCB1 cannabinoid receptor-mediated modulation of food intake in mice.Cancer cachexia update in head and neck cancer: Pathophysiology and treatment.Symptom control.Symptom management in metastatic breast cancer.Treatment of unintentional weight loss in patients with cancer.Guidelines for the use of orexigenic drugs in long-term care.Cannabinoids in pancreatic cancer: correlation with survival and pain.Sex differences in cannabinoid-regulated biology: A focus on energy homeostasisIntegrating cannabis into clinical cancer care.Evaluation and management of patients with pulmonary nontuberculous mycobacterial infections.Pentoxifylline treatment in patients with cancer cachexia: A double-blind, randomized, placebo-controlled clinical trialPharmacological options for advanced cancer patients with loss of appetite and weight.Megestrol acetate in cachexia and anorexiaDrugs in development for treatment of patients with cancer-related anorexia and cachexia syndrome.Overview of emerging pharmacotherapy in chronic heart failure.Nonsteroidal selective androgen receptor modulator Ostarine in cancer cachexia.Update on emerging drugs for cancer cachexia.Medical marijuana: A panacea or scourge.Quality of life and supportive care for patients with metastatic renal cell carcinoma.A systematic review of health-related quality of life instruments in patients with cancer cachexia.
P2860
Q22299116-AB18B8D3-2E7F-46CA-8C5D-FE37AB5759B4Q24600806-6C866B60-6EB2-4CEC-9467-5DA897326795Q26862841-DA91BC55-C548-487D-ACF2-F606DD03621AQ28082785-718E0226-98A1-46BB-AAF2-086D7ADEF1A2Q28818800-0755C9AB-F402-46C3-8594-45E8206AB614Q30494289-E874E7CB-499F-4F64-9E3B-E6D3F9652B30Q33741103-0C7CD246-E8CA-4CA5-9943-28EA55C5B100Q33956866-C68E9EEC-A9AE-489A-8D7B-9F574111E044Q33994400-8ADF5318-1906-42B4-92A4-B12827431B2DQ34005616-544CACFB-E89F-4084-B3CD-867A1F8C6B81Q34158188-70DB0BD8-7882-4F2A-B4C6-258D5E6BC300Q34215052-09BE69C5-C0BF-4875-B481-0249E9DE4302Q34284843-1BE07979-0714-47FB-8E90-A04D4A204298Q34368715-1682F92D-4CAF-45A0-BB71-1F278928C0FAQ34377446-E864EC7D-5F24-48FD-840B-65B06811E061Q34631019-DAC0A0E7-48FF-4EDC-8BB4-DC9AA3802D0EQ34660312-4EBAE29D-B588-4F5A-BF75-0C510C8DA438Q34669440-B9693162-36A4-4D3D-95F2-FD0AD72E9FA8Q34988386-961B4405-3C0D-49AD-96DE-FA54BFA6CFF5Q35019743-C2AC017A-8EDE-441F-B3A0-38269986C9D9Q35048878-44FE3FB6-E949-4789-9FC1-1FD320947D3FQ35122201-0D45506C-3B7D-49ED-83C8-FF3ABEF1E58FQ35553856-A68EF395-415E-4BC6-9DA8-D2BA0D050EF0Q35584763-90EE55D7-3746-4818-B712-75C0B28DD49FQ36278408-3C433816-71CF-4613-BA7B-7025430DD112Q36378763-6CF092D8-4535-4B92-8CEC-C82AD8F1FDA3Q36426977-603F34AD-6816-4A22-89A5-1ECB383E6447Q36665240-FDEE94A2-D214-46AA-A348-3E6BEAB07B9EQ36685151-EC162F60-885F-4C19-8B64-4EC974013E18Q36688950-723B483F-CD73-42CE-803F-B029D4B71F2AQ36801270-1394D52B-CEC3-4BF6-B617-D1A6102E97D0Q36828134-E082264B-A61F-4E8B-8D4F-6922D319F42CQ36920325-4AE99574-22D9-4E6E-B5A1-5D79549BDA56Q37103603-129CE46C-8ACA-4FB0-AEE8-37BBC3C05F17Q37552943-9E51BA0D-7795-4F3C-B64C-B0C4F5E00EA7Q37620387-2F48A58F-996B-423E-8D39-E93B9609A4D2Q37622253-E55EBF2B-D83B-47C5-B294-4277FD9AF035Q37723348-C8F528D0-B999-414D-B2FD-5163B9FB465DQ38017587-82D2D808-507B-441C-B18C-17F67BFBE23CQ38116773-02A610B4-7C4A-48C9-BEEF-62E19F9FE8BA
P2860
Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Dronabinol versus megestrol ac ...... Cancer Treatment Group study.
@ast
Dronabinol versus megestrol ac ...... Cancer Treatment Group study.
@en
type
label
Dronabinol versus megestrol ac ...... Cancer Treatment Group study.
@ast
Dronabinol versus megestrol ac ...... Cancer Treatment Group study.
@en
prefLabel
Dronabinol versus megestrol ac ...... Cancer Treatment Group study.
@ast
Dronabinol versus megestrol ac ...... Cancer Treatment Group study.
@en
P2093
P356
P1476
Dronabinol versus megestrol ac ...... Cancer Treatment Group study.
@en
P2093
Aminah Jatoi
Brad Christensen
Carl G Kardinal
Charles L Loprinzi
Harold E Windschitl
James A Mailliard
James E Krook
Jeff A Sloan
Paul J Novotny
Sarode Pundaleeka
P304
P356
10.1200/JCO.20.2.567
P407
P577
2002-01-01T00:00:00Z